Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer

Merck KGaA, Darmstadt, Germany · 2007
ClinicalTrials.gov · Datasets · License: Public Domain · 2007
Open Source ↗
breastcancer
breast neoplasm, cancer, breast, metastatic, triple negative, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 879570
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.